AGTR1: Type-1 angiotensin II receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor for angiotensin II, a vasoconstricting peptide, which acts as a key regulator of blood pressure and sodium retention by the kidney.
- Drugs that act on it: 18
- With a US drug page: 10
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Angiotensin ii | Approved | Type-1 angiotensin II receptor agonist | Agonist | — |
| Candesartan cilexetil | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Eprosartan | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Irbesartan | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Losartan | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Olmesartan medoxomil | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Saralasin | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| Sparsentan | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Telmisartan | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Valsartan | Approved | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Azilsartan | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| Azilsartan medoxomil | — | Type-1 angiotensin II receptor antagonist | Antagonist | Boxed warning |
| Candesartan | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| Fimasartan | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| Olmesartan | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| Pratosartan | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| Tasosartan | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
| TRV-120027 | — | Type-1 angiotensin II receptor antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Renal tubular dysgenesis
- 0.75
- Hypertensive disorder
- 0.74
- Renal tubular dysgenesis of genetic origin
- 0.72
- Heart failure
- 0.62
- Essential hypertension, genetic
- 0.61
- Congestive heart failure
- 0.61
- Kidney disorder
- 0.61
- Stroke disorder
- 0.60
- Cardiovascular disorder
- 0.59
Drugs and mechanisms are from ChEMBL CHEMBL227 (CC BY-SA 3.0). Gene name, function (UniProt P30556, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets